San Francisco, California, July 11, 2017: TMR Research’s report “Immunohistochemistry Market – Global Industry Analysis, Size, Share, Volume, Growth, Trends, and Forecast 2017 – 2025,” gives a detailed analysis and forecast for the market. Immunohistochemistry is a developing market which assures a bright future to the clients.
Immunohistochemistry is a selective imaging process of antigens in which the cells of a tissue section are used to bind the antigens to antibodies in biological tissues. Immunohistochemistry is majorly used to analyze irregular cancer like cells.
The supply and demand chain for the global immunochemistry market has been scaling up over the recent past, contributing to growth in market shares. Key factors boosting the global immunohistochemistry market are the gaining awareness among physicians and the continuously increasing demand for histopathology. Also, people are increasing their spending on healthcare and diagnostic centers which causes growth of the immunohistochemistry market. Besides these, the high demand for personalized medicines is a key growth driver for immunohistochemistry market.
Recent research shows that immunohistochemistry is being included in the experimental treatment of Parkinson’s disease, ensuring steady growth of the market. Present CAGR of the global immunohistochemistry market is quite healthy and promises a considerable growth in the coming years. Similar to the regional market of India and China, the global market would also make the most of the increasing awareness, the growing demand for histopathology, and healthcare infrastructure. The only disadvantage of immunohistochemistry is that contrasting immunoblotting techniques where discoloration is tested against molecular weight ladder, it is unmanageable to show in immunohistochemistry that the discoloration corresponds to a protein of concern. Because of this reason, primary antibodies must be confirmed in a western blot.
According to analysts, India, China and Brazil are some of the emerging nations exhibiting lucrative opportunities. Globally, North America and Europe are likely to showcase considerably high demand for immunohistochemistry. Due to the increasing number of cancer patients and improving healthcare infrastructures, there has been a rapid growth of immunochemistry procedures in Asia-Pacific, Latin America, and the Middle East and Africa. Out of these regions, Asia Pacific and Latin America are likely to show a higher growth rate than the present, according to the research team. Additionally, there is a lot of healthy competition between the regional vendors and the top global vendors. Due to the irreplaceable applications of immunochemistry today, its global market is likely to remain consistent in its rate of growth.
Some of the key players that contribute in the global immunohistochemistry market are Cell Signaling Technology, Inc., Merck Millipore, PerkinElmer, Inc., Bio SB Inc., Agilent Technologies, Inc., Abcam plc, Thermo Fisher Scientific Inc., Danaher Corporation, Bio-Rad Laboratories, Inc., and F. Hoffman-La Roche AG.